Skip to content
DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS

Centres Of Excellence

Our Centres of Excellence bring together multidisciplinary teams to deliver precise diagnosis, advanced treatments, and superior outcomes across a wide spectrum of medical specialties.

Medical professionals in hospital setting

OVERVIEW

The primary goal of epilepsy treatment is the elimination of clinical seizures without causing unacceptable side effects. Treatments fall into four clinical categories: antiseizure medications (ASMs), resective or destructive epilepsy surgery, neuromodulation devices (such as vagus nerve stimulation), and specialized dietary therapies (such as the ketogenic diet). The underlying mechanism of anti-seizure therapy relies on modulating ion channels, enhancing gamma-aminobutyric acid (GABA)-mediated inhibition, or reducing glutamate-mediated excitatory neurotransmission in cerebral neuronal networks.

PROCEDURE

Epilepsy management is structured across distinct diagnostic and therapeutic stages. First, clinicians perform comprehensive baseline diagnostics, including 3T structural brain MRI, video-EEG monitoring, and neuropsychological evaluation. Second, pharmacological management is initiated using monotherapy, titrating the dose incrementally every 1 to 2 weeks until seizure freedom is achieved or side effects emerge. Third, if seizures persist after two failed medication trials, presurgical evaluation is initiated, including functional MRI, PET scan, SPECT scan, and invasive intracranial EEG (stereo-EEG) if needed. Fourth, for surgical candidates, procedures such as anterior temporal lobectomy, lesionectomy, laser interstitial thermal therapy (LITT), or implantation of neuromodulation devices (VNS, RNS, or DBS) are performed. Fifth, long-term clinical monitoring involves regular clinical appointments, therapeutic drug monitoring, routine laboratory surveillance, and ongoing assessment of cognitive and psychosocial functioning.

BENEFITS

Evidence-based epilepsy treatments offer several established clinical benefits validated across randomized controlled trials and national guidelines (NICE NG217; Kwan & Brodie, 2000):

  • Seizure Control and Freedom: Approximately 60% to 70% of individuals achieve sustained seizure freedom with appropriately selected antiseizure monotherapy or dual therapy.
  • Reduction in Mortality: Effective seizure suppression significantly reduces the risk of Sudden Unexpected Death in Epilepsy (SUDEP) and trauma related to loss of consciousness.
  • Neurocognitive and Psychological Stabilization: Reducing seizure frequency decreases post-ictal cognitive dysfunction, head injury risks, and secondary mood disturbances.
  • Improved Functional Independence: Achieving seizure freedom enables individuals to meet clinical standards for driving, employment, and unassisted daily living activities.
  • Curative Potential with Surgery: Selected candidates with drug-resistant focal epilepsy undergoing resective surgery achieve long-term seizure freedom in 60% to 80% of cases (Englot et al., 2012).

RECOVERY

Recovery trajectories vary based on the treatment modality. Pharmacological initiation requires a titration phase lasting 4 to 12 weeks to achieve therapeutic steady-state plasma concentrations while monitoring for adverse effects. For resective epilepsy surgery, inpatient hospitalization ranges from 3 to 7 days, with initial wound healing occurring over 2 to 4 weeks, and complete cognitive and physical recovery taking 3 to 6 months. Post-surgical seizure outcomes are typically evaluated at 6, 12, and 24 months using standardized scoring systems such as the Engel Surgical Outcome Scale or the ILAE Outcome Scale. Long-term follow-up includes ongoing EEG surveillance and gradual medication weaning when appropriate.

WHAT WE TREAT

Epilepsy treatment addresses a broad range of seizure types and epileptic syndromes defined by the International League Against Epilepsy (ILAE). Key indications include focal onset seizures (motor and non-motor), generalized onset seizures (tonic-clonic, absence, myoclonic, and atonic), and unknown onset seizures. Specific epileptic encephalopathies and syndromes managed include Dravet syndrome, Lennox-Gastaut syndrome, juvenile myoclonic epilepsy, temporal lobe epilepsy, and structural epilepsies secondary to stroke, traumatic brain injury, brain tumors, or cortical dysplasias.

PREPARATION

Preparing for epilepsy treatment requires a systematic clinical assessment. Patients undergo thorough history taking, including witness accounts of seizure semiology, family history, and detailed medication records. Diagnostic preparation involves high-resolution neuroimaging (epilepsy-protocol MRI) and electroencephalographic testing (routine or long-term video-EEG monitoring). Laboratory workup includes complete blood counts, hepatic and renal function panels, baseline electrolyte measurements, and genetic screening where indicated (such as HLA-B*1502 testing prior to carbamazepine in populations of Asian ancestry). Patients are instructed to maintain a detailed seizure diary recording event times, triggers, semiology, and potential drug side effects.

RISKS

Risks associated with epilepsy treatments are categorized by therapeutic modality. Antiseizure medications carry risks of neurological side effects (somnolence, dizziness, ataxia, cognitive slowing), idiosyncratic cutaneous reactions (ranging from mild rashes to life-threatening Stevens-Johnson syndrome), organ toxicity (hepatotoxicity, bone marrow suppression), and teratogenicity (such as neural tube defects associated with valproate). Surgical interventions carry risks of intracranial hemorrhage, wound infection, cerebrospinal fluid leak, transient or permanent neurological deficits (visual field deficits, speech dysfunction, memory decline), and anesthetic complications. Neuromodulation devices carry risks of hardware infection, lead displacement, hoarseness, cough, and surgical site pain.

JOURNEY

The clinical care pathway for epilepsy begins with comprehensive diagnostic evaluation, including electroencephalography (EEG), high-resolution magnetic resonance imaging (MRI), and clinical seizure semiology classification. Initiation of therapy typically starts with single-drug monotherapy tailored to the specific seizure type. Patient monitoring involves titration to therapeutic doses, assessment of seizure frequency via patient logs, and surveillance for side effects. If seizures persist despite trials of two appropriately chosen and tolerated ASMs, the condition is classified as drug-resistant epilepsy, triggering evaluation at a specialized epilepsy center for surgical, device-based, or dietary treatment alternatives.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Hisar Intercontinental Hospital

Hisar Intercontinental Hospital

Saray Mah. Siteyolu Cad. No:7, Umraniye, 34768, Istanbul, Turkey

Medical Park Group, Istanbul

Medical Park Group, Istanbul

Fahrettin Kerim Gokay Cad. Tıbbiye Cd., Kadikoy, Istanbul, Turkey

Emsey Hospital, Pendik, Istanbul

Emsey Hospital, Pendik, Istanbul

Çamlık, Selçuklu Cd. No:22, 34912 Pendik/İstanbul, Türkiye

LIV Hospital, Istanbul

LIV Hospital, Istanbul

American Hospital, Istanbul

American Hospital, Istanbul

Guzelbahce Sk. No:20, 34365, Nisantasi, Istanbul, Turkey

Memorial Hospitals Group

Memorial Hospitals Group

Burhaniye, Nagehan Sokağı No:4/A D:1, 34676 Üsküdar/İstanbul, Türkiye

Florence Nightingale Hospital Istanbul

Florence Nightingale Hospital Istanbul

Abide-i Hürriyet Cd No:166, 34381 Sisli, Istanbul

Medicana International Hospital, Istanbul

Medicana International Hospital, Istanbul

Halit Ziya Turkkani Mah. Medikal Park Cd. No:1, Beylikdüzü, İstanbul

Okan University Hospital Istanbul

Okan University Hospital Istanbul

Icmeler Mah. Aydınlıyolu Cd. No:2, 34947 Icmeler-Tuzla, Istanbul

Kolan International Hospital, Istanbul

Kolan International Hospital, Istanbul

Kaptanpasa Mah. Okmeydan Kavsagi, Darulaceze Cd. No:14, 34384 Sisli, Istanbul

Al Zahra Hospital, Dubai

Al Zahra Hospital, Dubai

Sheikh Zayed Road, Al Barsha 1, Dubai, UAE

Burjeel Medical City, Abu Dhabi

Burjeel Medical City, Abu Dhabi

28th Street, Mohammed Bin Zayed City, Abu Dhabi, UAE

Burjeel Hospital, Dubai

Burjeel Hospital, Dubai

Dubai, UAE (part of Burjeel Holdings network)

King's College Hospital, Dubai

King's College Hospital, Dubai

Dubai Hills, Mohammed Bin Rashid City, Dubai, UAE

Neuro Spinal Hospital (NSH), Dubai

Neuro Spinal Hospital (NSH), Dubai

Dubai Science Park, Umm Suqeim St, Al Barsha South, Dubai, UAE

HMS Al Garhoud Hospital, Dubai

HMS Al Garhoud Hospital, Dubai

Al Garhoud Street, Al Garhoud, Dubai, UAE

Canadian Specialist Hospital, Dubai

Canadian Specialist Hospital, Dubai

Abu Hail Street 269/1, Canadian Specialist Hospital Building, Hor Al Anz East, Deira, Dubai, UAE

NMC Royal Women's Hospital, Abu Dhabi

NMC Royal Women's Hospital, Abu Dhabi

Tower B, Mohammed bin Zayed Stadium, Al Jazira Club, Opposite Dusit Thani, Muroor Road, Abu Dhabi, UAE

NMC Specialty Hospital, Al Nahda, Dubai

NMC Specialty Hospital, Al Nahda, Dubai

7A St, Al Qusais, Al Nahda 2, next to Bait Al Khair Building, Dubai

Bangkok Hospital, Thailand

Bangkok Hospital, Thailand

2 Soi Soonvijai 7, New Petchburi Road, Huay Khwang, Bangkok 10310, Thailand

Booking With DIVINHEAL

Get a free consultation to understand your treatment options